CEO Feldschuh Buys 1,000 Shares of Daxor Corp at $9.07 – Insider Confidence Signals Bullish Outlook
CEO Feldschuh’s fresh 1,000‑share buy at $9.07 shows confidence in Daxor’s blood‑volume tech launch and bullish stock outlook amid rising investor interest.
3 minutes to read


